Skip to main content
. 2015 Mar 18;10(3):e0119272. doi: 10.1371/journal.pone.0119272

Table 1. FOXC1 gene variations identified in dominant glaucoma cases and associated clinical features.

Proband or family member 1 Nucleotide change Amino acid change Phenotype/laterality Age at diagnosis (years)/sex IOP (mmHg) at diagnosis (OD/OS) C/D (OD/OI) 2 Treatment
PCG68 (III:1) 3 c.141C>G 3 p.Y47X LCG/B 7/F (24/20) NA 1
PCG68 (II:4) c.141C>G p.Y47X JOAG/B 30/F 30/25 0.8/0.8 5+Surgery
559–10 (II:1) c.316C>T p.Q106X PCG/B 3/F (25/25.9) NA Surgery
PCG73 (III:1) 3 c.377T>G 3 p.I126S PCG/B 1/F (14/15) (0.6–0.7/0.8–0.9) 1+Surgery
PCG73 (II:2) c.377T>G p.I126S JOAG/NA 12/F NA NA NA
PCG73 (II:4) c.377T>G p.I126S ARA/B NA/M NA NA NA
556–10 (II:2) 3 c.1337_1342dup 3 p.G447_G448insDG AOG/B 66/F (21/20) NA 1
556–10 (II:3) c.1337_1342dup p.G447_G448insDG AOG/B >50/F NA NA NA

1The variants were present in the heterozygous state;

2Number of drugs and/or surgery;

3Novel variants;

AOG/ARA/JOAG/LCG/PCG: Adult-onset glaucoma/Axenfeld-Rieger anomaly/juvenile-onset glaucoma/late-onset primary congenital glaucoma/primary congenital glaucoma; B: bilateral; C/D: cup/disk ratio; NA: Not available; OD/OS: right eye/left eye. Mutations were named according to RefSeq: NM_001453.2 and using directions from Mutalyzer (https://humgenprojects.lumc.nl/trac/mutalyzer).